NRC Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio44.64Forward 17.21
EPS (TTM)$0.39-44.0% YoY
Profit margin6.5%HEALTHCARE
Market cap$392.4MSmall cap
Valuation
- Forward P/E
- 17.21
- PEG ratio
- 1.32
- P/B
- 28.96
- P/S (TTM)
- 2.83
- EV/EBITDA
- 16.73
Profitability & growth
- ROE (TTM)
- 41.9%
- Operating margin
- 16.0%
- Revenue growth YoY
- 3.7%
- Dividend yield
- 3.4%
- Beta
- 0.41
Last earnings
Feb 2, 2026 · Estimate $0.00 · Reported $0.08
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About National Research Corp
Company profileNational Research Corporation provides analytics and information that make it easy to measure and improve the patient and employee experience in the United States and Canada. The company is headquartered in Lincoln, Nebraska.
Classification
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 1245 Q STREET, LINCOLN, NE
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$392.4M
Shares outstanding$22.5M
52W high$22.58
52W low$10.82
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
B
Agent
The AI built for clarity
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer
B
Agent